Antenatal corticosteroids in late preterm infants: Limited evidence suggests no effect on respiratory disorders or other complications of late prematurity

BMJ

Volumn 342, Issue 7802, 2011, Pages

  Roberts, Devender ^a  

^a LIVERPOOL WOMEN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; LUNG SURFACTANT; PLACEBO;

ANTIOXIDANT ACTIVITY; BRAIN HEMORRHAGE; CHILD; DRUG EFFICACY; EDITORIAL; EVIDENCE BASED MEDICINE; FETUS LUNG; FETUS LUNG MATURATION; HUMAN; INCIDENCE; LUNG VOLUME; MORBIDITY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN CARE; NEWBORN MORTALITY; PRACTICE GUIDELINE; PREMATURITY; PRENATAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; TACHYPNEA; BREATHING DISORDER; FEMALE; GESTATIONAL AGE; NEWBORN; NOTE; PREGNANCY;

ADRENAL CORTEX HORMONES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PREGNANCY; PRENATAL CARE; RESPIRATION DISORDERS;

EID: 79954590439     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d1614     Document Type: Editorial

References (10)

1. Roberts D. Antenatal corticosteroids to reduce neonatal morbidity and mortality. Greentop Guideline No 7. Royal College of Obstetrics and Gynaecology, 2010.
2. Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;3:CD004454.
3. Hofmeyr GJ. Antenatal corticosteroids for women at risk of preterm birth: RHL commentary (last revised: 2 February 2009). WHO Reproductive Health Library. WHO, 2009.
4. Pattanittum P, Ewens MR, Laopaiboon M, Lumbiganon P, McDonald SJ, Crowther CA; SEA-ORCHID Study Group. Use of antenatal corticosteroids prior to preterm birth in four South East Asian countries within the SEA-ORCHID project. BMC Pregnancy and Childbirth 2008, 8:47.
5. Mwansa-Kambafwile J, Cousens S, Hansen T, Lawn JE. Antenatal steroids in preterm labour for the prevention of neonatal deaths due to complications of preterm birth. Int J Epidemiol 2010;39(suppl 1):i122-33.
6. Porto AMF, Coutinho IC, Correia JB, Amorim MMR. Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial. BMJ 2011;342:d1696.
7. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515-25.
8. Amorim MM, Santos LC, Faundes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. Am J Obstet Gynecol 1999;180:1283-8. (Pubitemid 29259030)
9. Kramer MS, Demissie K, Yang H, Platt RW, Sauvé R, Liston R. The contribution of mild and moderate preterm birth to infant mortality. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System. JAMA 2000;284:843-9.
10. Wang ML, Dorer DJ, Fleming MP, Catlin EA. Clinical outcomes of near-term infants. Pediatrics 2004;114:372-6. (Pubitemid 39006664)